Blog
Why does PSYSCAN use CANTAB?
PSYSCAN is a global project, which aims to develop a neuroimaging-based tool that will help healthcare professionals to address key clinical issues for patients with psychotic disorders. We caught up with study coordinator – Aimée Westerveld – to find out more about the role of CANTAB in the project.
Examining the Neural Basis of Psychotic-like Experiences in Adolescence
We caught up with Dr Evangelos Papanastasiou to discuss his latest publication, and the next steps for improving the early diagnosis of psychotic illness.
web-based testing,
wearables,
virtual clinical trials,
technology,
swm,
subjective measures,
stigma,
social cognition,
smartphones,
sleep,
schizophrenia research,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
regulations,
recruitment,
rare disease,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
paired associates learning,
ots,
occupational health,
normative data,
neuroscience,
neurology,
near-patient testing,
multiple sclerosis,
mts,
ms,
modelling,
mental wellbeing,
mdd,
mci,
major depression,
machine learning,
life at cambridge cognition,
high-frequency testing,
high frequency,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
ebt,
early career researchers,
early alzheimer's disease,
drug development,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab,
cambridge cognition,
brain health,
biomarkers,
automatic speech recognition,
autism,
attention,
asr,
alzheimer's disease,
academic,
absenteeism,
